Literature DB >> 217430

Interaction of plasma lipoproteins with erythrocytes. II. Modulation of membrane-associated enzymes.

D Y Hui, J A Harmony.   

Abstract

When incubated with intact erythrocytes, low density lipoproteins (LDL) decrease the phosphate content of erythrocyte spectrin allowing the cells to undergo morphological transformation. The phosphate content of spectrin depends on the balance between the activity of membrane-associated cyclic AMP-independent protein kinases and phosphoprotein phosphates. LDL do not influence the activity of membrane-associated cyclic AMP-independent protein kinases; these lipoproteins activate by 2-fold and greater membrane-associated phosphatases as determined by hydrolysis of p-nitrophenyl phosphate and by phosphate hydrolysis of phosphorylated erythrocyte membrane proteins. We conclude that LDL interact at the exterior surface of the erythrocyte to stimulate dephosphorylation of spectrin. The significance of this conclusion is augmented by the fact that spectrin, the target for LDL-induced dephosphorylation, specifies cell morphology and modulates the distribution of cell-surface receptors. LDL also render erythrocyte acetylcholinesterase less susceptible to inhition by F-. Lipoproteins in the high density class (HDL) do not stimulate dephosphorylation of spectrin, and they are consequently unable to alter erythrocyte morphology. HDL do prevent the LDL-induced activation of membrane phosphatase. The inhibitory capacity of HDL is observed over the range of LDL:HDL (w/w) which exists in the plasma of normolipemic humans.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 217430     DOI: 10.1016/0005-2736(79)90146-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Inhibition of Ca2+ accumulation in mitogen-activated lymphocytes: role of membrane-bound plasma lipoproteins.

Authors:  D Y Hui; J A Harmony
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

2.  Increased lysolecithin acyltransferase activity in the plasma of type II hyperlipoproteinemic patients.

Authors:  P V Subbaiah; J T Ogilvie
Journal:  Lipids       Date:  1984-02       Impact factor: 1.880

3.  Correction of erythrocyte shape abnormalities in familial hypercholesterolemia after LDL-apheresis: does it influence cerebral hemodynamics?

Authors:  A Iannuzzi; G Bianciardi; F Faccenda; A Gnasso; N Scarpato; L Di Marino; G Iaccarino; C Simoes; G Sacchi; E Weber
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

4.  Phosphatidylinositol turnover in mitogen-activated lymphocytes. Suppression by low-density lipoproteins.

Authors:  D Y Hui; J A Harmony
Journal:  Biochem J       Date:  1980-10-15       Impact factor: 3.857

5.  Erythrocyte deformability improving action of beta-pyridylcarbinol tartrate.

Authors:  T Okada; A Okamoto; K Nakamura
Journal:  Experientia       Date:  1981

6.  Erythrocyte echinocytosis in liver disease. Role of abnormal plasma high density lipoproteins.

Authors:  J S Owen; D J Brown; D S Harry; N McIntyre; G H Beaven; H Isenberg; W B Gratzer
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.